Two training programs, one goal — Your feedback matters

Over the past months, EVOLVE2CARE has successfully wrapped up two insightful six-part training programs — one for HealthTech Innovators & Researchers, led by Anthology Ventures, and one for Living Labs, guided by ENoLL.

Across twelve sessions, we saw great participation, masterful speakers, and lively discussions that turned every meeting into a space for shared learning and collaboration. Together, we explored how innovation can move more quickly from the Living Labs to the market and how Living Labs can play a stronger role in supporting that journey.

Now, it’s your turn to assess the experience.

We invite all participants to share their feedback through our short questionnaires. Your insights will help us refine and improve future initiatives.

If you attended at least four out of six sessions, keep an eye on your inbox: your Certificate of Participation is coming soon!

The EVOLVE2CARE Open Call is still open! Take the next step and put what you have learned into practice; innovators and Living Labs are supported to collaborate and test a HealthTech solution in real-world conditions. Apply now: https://evolve2care.eu/open-call/

Measuring impact & Evaluating success: A recap of the final training session for Living Labs

The sixth and final webinar of the EVOLVE2CARE Training Series for Living Labs took place on 19 September 2025, with a focus on measuring impact and scaling pilots. This session, titled “Measuring Impact & Evaluating Success”, was led by Prof. Dr. Dimitri Schuurman, Senior Research Strategist at the European Network of Living Labs (ENoLL).

Key takeaways from the session

Understanding Living Lab characteristics

Prof. Schuurman emphasized the core elements that define a Living Lab, which include:

  • Multi-stakeholder: Living Labs engage a diverse group of stakeholders, including researchers, businesses, governments, and end-users. This broad collaboration ensures that innovation is inclusive and relevant to all parties involved.
  • Active user involvement: Ensuring the continuous feedback of users throughout the innovation process, from idea generation to final implementation.
  • Orchestration: Orchestration refers to the strategic coordination of all actors in the Living Lab. By aligning the interests and expertise of different stakeholders, Living Labs facilitate effective collaboration and drive the innovation process forward.
  • Co-Creation: Involving all relevant stakeholders in the design and development processes.
  • Real-Life Setting: Unlike traditional laboratories, Living Labs test solutions in real environments, which increases the relevance and applicability of the results.
  • Multi-Method Approach: Each Living Lab adapts its methods based on the problem and stakeholders involved, blending exploratory and confirmatory approaches.

Impact Models and Measuring Outcomes

One of the central frameworks discussed during the session was the Impact Model. This model is essential for understanding how to track the effectiveness of Living Labs over time. It incorporates the Theory of Change, which categorizes results into:

  • Input: Resources and efforts that go into the project.
  • Process: The activities and interactions that drive the project forward.
  • Output (Short-Term): Direct deliverables and tangible results produced immediately after implementation.
  • Outcome (Medium-Term): The effects of those outputs on the targeted stakeholders or systems.
  • Impact (Long-Term): The ultimate, lasting change or influence of the project, contributing to broader societal goals.

This model helps Living Labs track not just the immediate outputs, but also the long-term impacts, offering a roadmap for continuous improvement.


Living Lab Assessment Method


To effectively evaluate the impact of Living Lab projects, the Living Lab Assessment Method was introduced. It is designed to measure the effectiveness across six key areas:

  • Skill Capacity Enhancement
  • Instrumental Capacity Enhancement
  • Network Capacity Enhancement
  • Knowledge Capacity Enhancement
  • Agenda Setting
  • Real Solution Generation

These indicators are critical for understanding how well a Living Lab is contributing to innovation and systemic change in its targeted sector.
A heartfelt thank you to all participants who joined us for the six-part EVOLVE2CARE Training Program for Living Labs led by ENoLL from June to September 2025. Your engagement and contributions made this series a great success. In the coming weeks, all the session recordings will be made available at the ENoLL Living Labbers Academy, so you can revisit the valuable insights shared throughout the program. We look forward to continuing the journey of innovation with you!

Measuring impact & scaling pilots — Highlights from the last session for Innovators & Researchers

The final session of the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers was held on 19 September 2025, bringing the six-part journey to a close with a focus on how to measure meaningful outcomes and scale innovation with purpose. The session, titled “Measuring Impact & Scaling Pilots — Driving Evidence-Based Growth in Living Labs,” was led by Despoina Petsani, Project Manager at ThessAHALL – Thessaloniki Action for HeAlth & Wellbeing Living Lab.

Drawing from practical experience and Living Lab methodology, the session guided participants through the mindset and tools needed to move from small-scale pilot projects to real, system-level change.

From activities to outcomes

Despoina Petsani opened with a key challenge in innovation evaluation: many projects focus on reporting what they did (outputs), rather than what they achieved (outcomes). For example, counting users reached is not the same as understanding whether user behavior or well-being improved. To build real impact, innovators must start with clear goals and plan for measurable change from the beginning.

Planning for impact from day one

Participants were encouraged to define 2–3 priority outcomes before launching a pilot. These should be tied to the needs of users and stakeholders. The use of SMART indicators—Specific, Measurable, Achievable, Relevant, and Time-bound—was recommended to track progress clearly and objectively.

How to evaluate a pilot

Effective evaluation goes beyond proving that something worked. It explores how, why, and for whom it worked. Despoina presented a step-by-step evaluation framework that includes:

Defining pilot objectives (What are you trying to learn or prove?)
Set evaluation questions (e.g., Does this tool improve patient engagement in rural clinics?
Set evaluation questions (Who are your users? Where and how long will the pilot run?)
Set evaluation questions (Understand the “before” to measure the “after”)
Ethics and Privacy (Data protection, informed consent – especially in health and education sectors)

A mixed-methods approach was strongly recommended, blending quantitative and qualitative tools to provide both scale and depth.

Scaling pilots responsibly

Scaling isn’t simply about growing bigger—it’s about expanding what works, in ways that fit new contexts. Before scaling, a solution should show strong user feedback, positive outcomes, operational readiness, and a clear value proposition.

Three paths to scale were introduced:

  • Replication – Apply the same model in a similar setting – High control, but limited adaptability
  • Adaptation – Tailor to different user needs/settings – Maintain core principles, flex where needed
  • Dissemination – Spread knowledge, frameworks, and tools – Enable others to replicate/adapt independently
  • The instructor also emphasized the importance of partnerships, technology infrastructure, business model and policy and systems alignment.

Final reflections

The session closed with a strong message: evidence is essential for impact. It builds trust, informs decisions, and enables scale. Living Labs and innovators must embed evaluation early and treat it not just as a reporting tool, but as a driver of learning and growth.

What makes a Living Lab official? Highlights from the 5th webinar

On September 10, 2025, the EVOLVE2CARE Training Series for Living Labs continued with its fifth session, focusing on one of the most defining aspects of Living Labs: certification and standardization. Delivered by Gabriella Quaranta and Alessandra Tricarico of the European Network of Living Labs (ENoLL), the session unpacked not only the why of certification, but also the how—from evaluation frameworks and tools, to good practices and lessons learned.

Why certification matters

As Gabriella Quaranta explained, ENoLL certification for Living Labs is widely regarded as a global standard for user-driven innovation, reflecting a structural and methodological assessment of their maturity as an innovation ecosystem.

Harmonization: What is it?

A central theme of the session was harmonization. Gabriella Quaranta highlighted that ENoLL has developed a structured and comprehensive system to assess the maturity, sustainability, and impact of Living Labs. By harmonizing evaluations, ENoLL ensures consistency and quality assurance, while also providing guidance for improvement, enabling global collaboration, transparency, and accountability, and strengthening long-term sustainability.

This harmonized evaluation framework is built around six evaluation chapters, covering:

  • Strategy: Examines macro-level issues such as multi-stakeholder participation, the orchestration role of the Living Lab, collaboration strategies, and its overall business model.
  • Users & reality: Looks at collaboration with users, levels of engagement, and participation, with emphasis on iterative processes in real-life contexts and the correct use of tools and methods.
  • Operations: Evaluates how a Living Lab manages its operations, including infrastructure, equipment, and human resources.
  • Openness: Reviews the openness of processes, partnerships, and projects, as well as practices for feedback and intellectual property protection.
  • Value & Impact: Focuses on the development of co-created values and the identification of impact clusters generated by the Living Lab for its stakeholders.
  • Stability & Scale-up: Assesses financial and organizational stability, long-term sustainability, and the replication of strategies and practices across ecosystems.

Together, these chapters translate into 15 evaluation criteria, forming the backbone of certification.

Tools for Evaluation: Self-assessment and qualitative application

Certification is supported by two complementary tools, as Alessandra Tricarico pointed:

Self-Assessment Tool: A quantitative instrument that allows Livin Labs to assess their maturity and sustainability and following that gives them a customized evaluation report.

Qualitative Application Form: A narrative-based tool where applicants describe governance structures, business plans, internal and external communication, human resources, projects, available equipment and infrastructure, innovation partnerships and processes, and ownership of results. It is limited to 20 pages (plus annexes) and allows supplementary materials. Here, evaluators look not only at facts but also at the story of the Living Lab’s vision and practice.

By combining these two, certification captures both hard data and contextual insights, ensuring fairness, depth, and comparability.

Tips & good practices

To help applicants succeed, the speakers shared practical advice drawn from years of experience evaluating Living Labs:

  • Spend enough time preparing a proper assessment and compiling all supporting material.
  • Start working in advance, avoiding last-minute submissions.
  • In the qualitative application form, answer each question, keep responses to one page (excluding visuals), and ensure all documents are in English.
  • Provide a clear explanation of governance structures.
  • Prepare a business plan that transparently presents future strategies.
  • Detail human resources, specifying who is involved, in what roles, and with what expertise.
  • Describe equipment and infrastructure, emphasizing availability and access.
  • Highlight collaboration strategies, showing how diverse stakeholders are engaged beyond single-project contexts.

These tips underscored the importance of thoroughness, clarity, and forward-looking planning in the application process

What’s next?

The EVOLVE2CARE Training Series will conclude with its final webinar: “Measuring Impact & Evaluating Success” on September 24, 2025, at 15:00 CEST. This closing session will guide participants in defining key performance indicators (KPIs), assessing service design, and measuring the broader impact of Living Lab activities.

How HealthTech innovators can fundraise with confidence

The fifth session of the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers took place on 4 September 2025, delivering a deep and practical dive into the realities of startup fundraising. Led by Adriane Thrash, the session “Fundraising & Pitching: An Investor’s Guide” offered a no-nonsense guide to what investors actually look for—and how innovators can meet those expectations with clarity, strategy, and confidence.

One of the core themes of the session was understanding the different types of investors and what each brings to the table. Adriane Thrash broke down the key categories:

  • Angel Investors: Often the first to believe in a startup, angel investors typically invest at early stages. They are usually more flexible and founder-friendly but offer limited capital and may not always bring sector-specific expertise.
  • Venture Capitalists (VCs): VCs look for high-growth potential and scalability. They expect aggressive expansion, clear exit strategies, and strong returns. Their involvement often comes with structured oversight and performance expectations.
  • Corporate Investors: These investors seek strategic alignment with their own business goals. They may offer more than capital—such as access to distribution channels, technical resources, or regulatory support—but their priorities may shift based on internal strategy.
  • Impact Investors: Focused on measurable social or health outcomes alongside financial returns, impact investors are particularly relevant in HealthTech. They value mission-driven innovation and often require robust impact metrics.
  • Public funding sources: These include grants, subsidies, and innovation programs from national or EU-level institutions. While non-dilutive and mission-aligned, public funding often comes with strict eligibility criteria, reporting obligations, and longer timelines. Innovators must be prepared to demonstrate societal value, policy alignment, and long-term sustainability.

Choosing the right type of investor is as important as securing the funding itself.

Fundraising is a strategy, not serendipity

Adriane Thrash emphasized that fundraising is not about luck or charm—it’s about building a strategic plan that aligns with your startup’s stage, goals, and long-term vision. Innovators must understand their business fundamentals and be able to communicate them effectively.

Know your numbers — and your market

Investors want facts. That means knowing your TAM (Total Addressable Market), SAM (Serviceable Addressable Market), SOM (Serviceable Obtainable Market), your projected growth, your burn rate, and your financial runway. 

Transparency builds trust

One of the most important lessons: don’t hide problems. Investors are not deterred by challenges—they’re deterred by surprises. Be upfront about risks, gaps, and what you’re still figuring out. A founder who can clearly articulate both strengths and weaknesses earns credibility.

Pitching is communication

A strong pitch is built on clarity, confidence, and relevance. Adriane Thrash encouraged innovators to focus on storytelling—connecting the problem, solution, team, and market in a way that resonates. Avoid jargon, be concise, and tailor your message to the investor’s perspective.

Prepare for due diligence

Fundraising doesn’t end with the pitch. Adriane Thrash highlighted the importance of being ready for due diligence—the process where investors validate your claims, assess risks, and examine your operations. Innovators should have their data room organized, with financials, legal documents, team bios, and product details ready to share.

What’s next?

The final session of the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers, titled “Measuring Impact & Scaling Pilots — Driving Evidence-Based Growth in Living Labs,” will take place on 19 September 2025 at 15:00 CEST. It will focus on helping innovators define success through SMART metrics, design effective pilot evaluations, and use data to demonstrate real-world impact. Led by Despoina Petsani, ThessAHALL Project Manager at AUTH, the session will guide participants in generating the kind of evidence that funders, policymakers, and partners require to support and scale innovation.

Communication as the engine of innovation in Living Labs

The fourth session of the “Trainings on Service Design for Living Labs,” held on September 3, 2025, focused on building innovation networks and engaging stakeholders in meaningful ways. Titled “Building Innovation Networks: Communication and Engagement”, the webinar brought together four speakers who shared practical cases, conceptual frameworks, and tools for stakeholder engagement within Living Lab ecosystems.

Clara Garcia Blanch, Pilot Test Manager at the Social Digital Lab (Suara), opened the session with practical reflections on identifying and engaging stakeholders in co-creation processes. She stressed that while visible actors are crucial, hidden stakeholders often influence project outcomes in unexpected ways. Drawing from her experience, she underlined the importance of mapping, listening, and uncovering less obvious contributors in order to design inclusive and sustainable innovations.

Leen Broeckx, Panel Manager at LiCalab, presented how her organization structures stakeholder engagement in health and care innovation. LiCalab operates test environments involving citizens and care professionals, drawn from its own database, in real-life settings, and works in close collaboration with hospitals, residential care centres, and home care services. Leen explained how their stakeholders are categorized into internal and external, how their stakeholder analysis uses approaches such as power/interest grids to position actors and design suitable engagement activities. She described the identifying needs process, which includes workshops, expert interviews, and inspiration sessions. As an example, she presented the “Orion” dementia care case, where staff and users tested smart technologies such as bed sensors and smart lamps.

Marta I. De Los Ríos White, representing the European Network of Living Labs (ENoLL), provided the theoretical foundation for stakeholder engagement. She defined categories such as internal vs. external, primary vs. secondary, and direct vs. indirect stakeholders, while clarifying distinctions between stakeholders, users, and customers. Marta also highlighted the role of the Quadruple Helix Model, which positions the public sector, businesses, education and research, and civil society as central actors.

The instructor also shared practical tips and tricks for effective communication with stakeholders:

  • Be transparent: Clear communication builds trust and credibility.
  • Be adaptable: Be prepared to adjust communication strategies as projects evolve and stakeholder needs shift.
  • Ensure accessibility: Consider potential language barriers and disabilities by developing inclusive strategies.
  • Aim for two-way communication: Establish mechanisms for feedback and input rather than one-way dissemination.
  • Be present and responsive: Actively listen to stakeholder concerns, questions, and suggestions, and respond promptly.

Finally, she explained why citizens are essential stakeholders, because they:

  • Align the community’s projects with real local needs
  • Secure people’s long-term support to the community
  • Ensure social acceptance
  • Ensure transparency and accountability in decision-making and community operations
  • Empower people to make informed decisions
  • Boost innovation and creativity, bringing fresh ideas and solutions
  • Stimulate economic benefits for the people, such as job creation within the community

Concluding the session, the focus shifted to the Thessaloniki Active and Healthy Ageing Living Lab (Thess-AHALL), presented by Despoina Petsani, Research Associate at the AUTH Medical Physics and Digital Innovation Lab, showcasing how long-term citizen engagement and structured tools can transform a Living Lab into a robust innovation ecosystem. Despoina presented outcomes from projects such as Long Lasting Memories, showing impacts in cognitive and physical training. She also showcased practical tools: Accelup, a collaboration platform for innovators and Living Labs; PaneLab, a panel management platform; and a methodological guide (partners of experience) for citizen involvement. Thess-AHALL’s work demonstrates how trust, continuity, and structured tools help Living Labs evolve into strong innovation ecosystems.

What's next?

The training series will continue with its fifth session on Certification & Standardization of Living Labs, taking place on September 10, 2025, at 15:00 CEST. This upcoming webinar will explore the essential requirements for certification, the benefits of achieving it, and the international recognition it brings to Living Labs.

Responsible innovation: Legal & Ethical Essentials for Living Labs

The third session of the EVOLVE2CARE Living Labs Training Series took place on August 27, 2025, and focused on a critical yet often overlooked dimension of innovation: legal, ethical, and regulatory frameworks. As Living Labs operate in real-world environments with real users, understanding these frameworks is essential to ensure responsible, inclusive, and sustainable innovation.

The session featured two distinguished experts—Maria Iakovidou, Attorney at Law at the Supreme Court of Greece, LLM in Civil Procedure Law, MSc in Law & Informatics, Data Protection Officer (DPO), who opened the discussion with a legal deep dive into GDPR, consent, and intellectual property; and Dr. Abdolrasoul (Rasoul) Habibipour, Director of Botnia Living Lab and Associate Professor in Information Systems at Luleå University of Technology, who followed with practical insights on embedding ethics into Living Lab design through real-world case studies.

Legal Essentials for Living Labs

Maria Iakovidou opened the session with a comprehensive legal roadmap for Living Labs, covering:

Data Protection & GDPR

Living Labs often collect personal data through sensors, wearables, interviews, and digital platforms. Maria Iakovidou emphasized that GDPR applies whenever data relates to an identifiable person, and outlined the six core principles of lawful processing: lawfulness, purpose limitation, data minimization, accuracy, storage limitation, and confidentiality.

Informed Consent in Real-Life Settings

Consent, Maria Iakovidou explained, must be freely given in advance, specific, informed, and unambiguous—and must be obtained before any data is collected. In Living Labs, where testing often occurs in public or semi-public spaces, this becomes especially complex. She highlighted red flags such as bundled consent, lack of withdrawal options, and overly technical language.

She also addressed the documentation of consent, stressing the need for signed forms or digital tools, and the importance of making it easy for participants to say both “yes” and “no.”

Intellectual Property (IP)

Living Labs frequently co-create innovations with startups, researchers, and citizens. Maria Iakovidou urged participants to clarify IP ownership and licensing terms early, distinguishing between background and foreground IP. She recommended involving legal advisors in drafting collaboration agreements and defining usage rights to avoid disputes later.

Liability & Risk in experimentation and pilot phases

From allergic reactions to data breaches, Living Labs face real risks. Maria advised teams to assess risks before deployment, include insurance and liability clauses, and clearly define responsibilities in case of harm or failure.

Living Lab & Ethics

Dr. Abdolrasoul Habibipour presented a structured approach to integrating ethical and legal considerations into Living Lab design. He explored key principles such as stakeholder engagement, transparency, and real-life experimentation. He illustrated their application through case studies from EU projects like SynAir-G and U4IoT, highlighting practical strategies for managing consent, data protection, IP rights, and liability.

Real-World Case Studies

SynAir-G

This EU project co-developed air quality monitoring tools with children in schools. The ethical challenges were significant: children are a vulnerable group under GDPR, and the app collected sensitive data like health status and GPS location. Dr. Abdolrasoul Habibipour shared how the team addressed these issues through dual consent (parents + children), age-appropriate explanations, and national ethics approvals.

U4IoT

This case supported large-scale IoT pilots in domains like smart cities and healthcare. It uncovered common pitfalls: biometric data collected without explanation, lack of signage in public testing, and unclear data ownership. The team responded by developing GDPR toolkits, user dashboards to increase transparency, and promoting Data Protection Impact Assessments.

Practical Tools & Red Flags

Abdolrasoul Habibipour introduced a Living Lab Ethics Checklist covering seven key areas: data protection (GDPR), informed consent, IP, risk and liability, inclusion and vulnerability, transparency and communication, and ethics integration in design. He encouraged teams to use this checklist at every stage—from kickoff to pilot launch—and to normalize ethical reflection in team meetings.

What’s next?

The Living Labs Training Series continues with the fourth session: “Building Innovation Networks: Communication and Engagement”, taking place on September 3, 2025, at 15:00 CEST. This session will focus on the importance of building strong innovation networks and effective stakeholder engagement within Living Labs. Participants will learn how to engage stakeholders in service design, with a particular focus on the Accelup platform. 

Stay tuned—and remember, attending at least 4 out of 6 sessions earns you a Certificate of Attendance from the EVOLVE2CARE project!

From protection to strategy: How HealthTech innovators can leverage IP

The fourth session of the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers took place on 24 July 2025, bringing sharp focus to one of the most essential, and often overlooked, aspects of innovation: intellectual property (IP).

The session, titled “Unlocking IP Value – Protection, Collaboration & AI Innovations,” was led by Yannis Skoulikaris, Founder and Managing Director of PatentMind Netherlands BV, and former Director at the European Patent Office (EPO). PatentMind offers expert guidance based on deep knowledge of software patents, AI innovation, and international patent law.

What is Intellectual Property, and what does it protect?

The session outlined the four types of IP and what they protect:

1. Patents – Protect technical inventions and unique processes or products

Patentable examples include:

  • Algorithms, software methods, if embedded in a technical solution to a technical problem

2. Copyright – Protects code, content, and creative works

Patentable examples include:

  • Source code
  • Manuals
  • Graphics

3. Trademarks – Protect brands, logos and names

Used for:

  • Product names
  • Company logos

4. Trade secrets – Protect confidential information, algorithms and know-how

Includes:

  • Source more
  • Formulas
  • Client lists

The instructor highlighted that Intellectual Property is the secret weapon of innovators for protecting, managing, and unlocking value from their innovation.

Why does it matter?
  • Competitive advantage
  • Company Valuation & Investment
  • Licensing Opportunities
  • Legal defence & Risk mitigation

In the fast-evolving world of tech and AI, strong IP protection is crucial for staying ahead, attracting investors, and safeguarding innovation.

Patents in focus

Patents are one of the most powerful tools to protect and commercialize innovation—especially in HealthTech and AI-driven environments.

What can be patented?

To receive a patent, an idea must be novel and solve a real problem. The specific requirements vary slightly by region:

  • In Europe, the invention must provide a technical solution to a technical problem.
  • In the US, it must offer a useful solution to a practical problem.
Why do patents matter—particularly in tech and AI?
  • They protect your innovations from being copied by competitors.
  • They increase your company’s valuation and attractiveness to investors.
  • They create new licensing and collaboration opportunities.
  • Importantly, patent rights are granted to the applicant, not necessarily the inventor—making early filing and clear agreements essential.
How does the patenting process work?

The pathway from idea to protection follows a clear structure:

  • Search: First, check if your invention is new.
  • Application: File with the relevant patent office.
  • Search/Examination: Patent office reviews your application in an interactive process, involving the applicant.
  • Patent Granted
The power and peril of collaboration in IP

Collaboration is a cornerstone of innovation—but when it comes to Intellectual Property, shared ownership must be managed with clarity and care. Navigating shared IP ownership—whether with co-founders, collaborators, or licensees—requires balancing benefits and risks.

Why collaboration pays

Working with co-founders, collaborators, or licensees can accelerate development and expand your market reach. Benefits include:

  • Shared expertise and resources, fostering deeper innovation
  • Faster time-to-market through increased development capacity
  • Broader visibility via partner distribution and co-marketing channels

The risks without IP agreements

  • Ownership disputes – unclear title can derail projects
  • Usage conflicts – unauthorized use or overlapping commercialization
  • Enforcement issues or gridlock – difficult to license or defend jointly

Key takeaways

  • IP is a critical asset: Proactively identify, protect, and manage your intellectual property
  • Testing Innovation: Know which aspects of your work are eligible for protection
  • Collaboration: Always set clear IP agreements at the start of any partnership
  • AI’s unique IP challenge: Data, algorithms, and AI-generated works require tailored IP strategies
What’s next?

The next session in the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers is titled “Fundraising & Pitching Strategies – An Investor’s Guide for Innovators.” It will feature Adriane Thrash, Managing Partner at Anthology Ventures, as the special speaker.

The session is scheduled to take place on 4 September 2025 at 15:00 CEST and will offer expert insights on how to craft compelling pitches and navigate the fundraising process with confidence. Designed for innovators looking to connect with investors and elevate their ventures, this event is a key opportunity to gain strategic guidance from an industry leader.

Stay tuned as we continue to bridge the gap between innovation and market with practical knowledge for real-world success.

Founder’s lens: Building sustainable HealthTech solutions

The third online session of the EVOLVE2CARE Training Series for Innovators and Researchers took place on 17 July 2025, offering a grounded and insightful look into the entrepreneurial path of a HealthTech founder. Titled “Building a Sustainable HealthTech Business – A Founder’s Journey,” the session was led by Panagiotis Katsaounis, Medical Geneticist and CEO of Metabio, a company pioneering IT solutions for biobanks. 

The session formed part of the six-part EVOLVE2CARE series From User to Market – Faster Validation and Commercialisation for HealthTech Innovators and Researchers, which supports HealthTech innovators working in Transitional Care and Clinical Pathways to accelerate their journey from research to real-world impact.

Why biosamples matter — and Why managing them is hard

Biosamples are a cornerstone of biomedical research and power medical R&D excellence, supporting advancements in diagnostics, drug discovery, genetics and environment.

However, IT systems to manage biosamples and associated data are often inadequate and problematic for researchers; unreliable, leading to poor data harmonization across sources; and limited, failing to capture the historical dimension of biosample usage. As a result, valuable data remains underutilized or inaccessible. 

This challenge laid the groundwork for the creation of Metabio, a next-generation IT platform designed to modernize and integrate the full spectrum of biosample data. By offering real-time access, harmonized metadata, and GDPR/HIPAA-compliant tools, Metabio enables biobanks, researchers and the entire research ecosystem to unlock the true potential of the biosample collections.

Key highlights

Identifying the real value

The instructor described how Metabio emerged from direct experience in the lab, where data quality gaps and outdated biobank IT systems conflicted with cost and time constraints.

Building the business model

Participants were guided through Metabio’s evolution from an idea to a revenue-generating SaaS platform. 

A breakdown of real startup costs revealed a balanced allocation:

  • 35% for team and operations
  • 30% for R&D and clinical validation
  • 20% for sales and marketing
  • 15% for regulatory compliance

This financial transparency highlighted the importance of lean spending, focused prioritization, and resource-efficient scaling.

Practical advice for HealthTech founders

Panagiotis Katsaounis shared several turning points, including a major shift from offering physical infrastructure to delivering modular, interoperable software. He emphasized that being responsive to market feedback and recognizing internal limitations were critical to navigating early-stage uncertainty.

The session closed with a set of key takeaways aimed at helping other innovators design more viable and resilient ventures:

  • Prioritize Speed and Iteration: Avoid over-engineering early on. Launch MVPs quickly rather than chasing perfection.
  • Cultivate deep customer and patient empathy: True innovation starts with understanding. Invest time in interviews, shadowing, and co-creation.
  • Build resilience and a supportive network: Surround yourself with a core team that shares the long-term vision. Replace doubt with determination.

What’s next

The upcoming session “Unlocking IP Value: Protection, Collaboration & AI” on Thursday 24 July, 2025, at 15:00 CEST, will explore how to protect intellectual assets, manage innovation in collaborative environments, and navigate new IP challenges in the age of artificial intelligence.

Stay with us as we continue to equip innovators with the tools to build, scale, and sustain meaningful healthtech solutions—from user to market.

Applying Service Design in Living Labs: Webinar highlights

The second session, titled “Designing Tailored Living Lab Services for Innovators”, which is part of the Living Labs Training Series, took place on 9 July 2025. It focused on designing structured, user-oriented services that enable Living Labs to better support innovators, accelerate experimentation, and ensure sustainable operations.

This six part training program is specifically crafted for Living Lab managers, researchers, and innovation professionals. It brings together top experts in service design and real-world practitioners from across Europe. The last webinar featured contributions from:

What is Service Design?

Francesca Sperandio opened the session by introducing the central question: “What is Service Design?” She explained that Service Design is about intentionally planning and organizing all the different touchpoints and interactions—from users and staff to platforms and operations—that collectively make up a service. 

  • Service Design is human-centered, evidence-based, and follows an iterative, collaborative process.
  • Living Labs, likewise, emphasize active user involvement, real-life experimentation, and co-creation.

Case Studies from the Thessaloniki Action for Health & Wellbeing Living Lab

In her turn, Despoina Petsani shared two concrete case studies from the Thessaloniki Action for Health & Wellbeing Living Lab, developed within the framework of the VITALISE project. VITALISE enables researchers from various disciplines to access European Living Lab infrastructures through Transnational Access.

These examples highlighted not only the innovative services developed—such as ASSURE, an AI tool for dysphagia detection, and HESTIA, a thermal monitoring system to support informal caregiving—but also the concrete resource needs involved in delivering them.

For each pilot, she presented a side-by-side comparison of time and personnel dedicated by internal and external teams. Internal refers to the Living Lab’s own staff, who are familiar with lab protocols, logistics, and stakeholder engagement, while external refers to visiting researchers granted access through the project.

The data showed needs for 170h/30d internal vs. 52h external for ASSURE project, and 121/28d internal vs. 14d external for HESTIA—demonstrating that effective Living Lab services require considerable coordination and time investment.

Structuring and Pricing Living Lab Services

Marta I. De Los Ríos White guided participants through a practical methodology for turning Living Lab activities into repeatable, well-defined services. 

The structured 5-step Servive Design Process included:

  1. Discover: the phase of immersion, where tools like interviews, observations, and self-documentation help capture real user needs and contextual insights.
  2. Define: a period of analysis—making sense of the findings, spotting patterns, and setting a clear design challenge.
  3. Develop: the creative core of the process, where ideas are generated, sketched, and prototyped through both visual and tactile methods.
  4. Deliver: this stage transforms ideas into action—pitching, role-playing, testing, gathering feedback, and capturing learnings.
  5. Evolve: a forward-looking stage focused on scaling, building partnerships, tracking impact, and celebrating even subtle change.

Do you know how to price your services?

To close, Marta I. De Los Ríos White presented three guiding steps for Living Labs ready to define the value of what they offer. First, she encouraged participants to assess the value their services provide to innovators, including the time saved, risk reduced, and unique benefits delivered. Next, she stressed the importance of understanding internal costs—factoring in people’s time and expertise, specialized tools, resources, and overhead. Finally, she highlighted the need to align pricing strategies with the Living Lab’s broader mission and funding model, ensuring financial sustainability while staying true to core objectives.

What’s next?

The next session for Living Labs, “Navigating Legal, Ethical & Regulatory Frameworks,” will take place on August 27, 2025, at 15:00 CEST, and will approach the ethical, legal and regulatory frameworks, explores the sector-specific compliance and engages with regulatory bodies.